Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has announced that it will report its second quarter 2026 financial and operating results on Thursday, 30 July 2026, before the U.S. financial markets open.
The company said it will host a conference call and simultaneous webcast at 8:30 AM Eastern Time on the same day.
Participants will be able to access the live webcast through the Investors and Media page of Regeneron’s website. Those wishing to join by telephone are required to register in advance and will receive a confirmation email with the dial-in number, unique passcode and registrant ID.
A replay and transcript of the conference call and webcast will be available on the company’s website for at least 30 days.